Postural hyperventilation as a cause of POTS
POTS is diagnosed by heart rate. When you stand, your heart rate rises by 30 beats per minute or more within ten minutes, and a clinician can call it POTS. What this evaluation does not measure is whether the tachycardia is the problem or whether it is the system's response to a problem that began somewhere else. A 2018 paper by Julian Stewart in the Journal of the American Heart Association documents one such upstream driver: postural hyperventilation. In a subset of POTS patients, standing triggers involuntary overbreathing that drops CO₂, constricts cerebral vessels, and reduces brain blood flow — and the tachycardia follows from that. Treat the heart rate and the mechanism is untouched.
The Postural Hyperventilation Mechanism: How Standing Triggers the Chain
Carbon dioxide is the primary regulator of cerebral vascular tone. When CO₂ rises, cerebral vessels dilate to increase blood flow. When CO₂ falls — as it does during hyperventilation — cerebral vessels constrict. This is not a subtle effect. A drop in end-tidal CO₂ of several mmHg produces a measurable reduction in cerebral blood flow velocity. The brain is one of the tissues most sensitive to CO₂-driven vascular regulation.
In Stewart's 2018 study, a specific POTS subtype was identified in which standing triggered an increase in ventilation that drove CO₂ below normal range — hypocapnia. This postural hyperventilation was not dramatic or clinically obvious. Patients were not visibly gasping. They were simply breathing slightly too fast and too shallowly for their metabolic needs in the upright position, exhaling more CO₂ than their activity level warranted. The result was a measurable drop in end-tidal CO₂ and a corresponding fall in cerebral blood flow velocity.
The cerebral hypoperfusion triggered sympathetic activation. The sympathetic nervous system, sensing inadequate brain perfusion, escalated heart rate and vascular resistance in an attempt to drive more blood upward. This is the tachycardia that defines the POTS diagnosis. But in this subtype, the tachycardia is the fourth event in a chain: standing → hyperventilation → hypocapnia → cerebral vasoconstriction → sympathetic escalation → tachycardia. The standard POTS evaluation measures only the last step.
The Reversal Experiment: CO₂ as Driver, Not Consequence
The most important finding in the paper is the reversal experiment. Stewart restored CO₂ to normal levels in these patients during upright posture — either through rebreathing protocols or controlled CO₂ supplementation — and measured what happened to the hemodynamics.
The abnormal upright physiology shifted toward normal. Cardiac output improved. Systemic vascular resistance, which had been elevated, normalized. Cerebral blood flow velocity recovered. Symptoms improved. This is not a correlation. CO₂ was the independent variable. The hemodynamic abnormalities were the dependent variable. When CO₂ returned to normal, the downstream consequences of its absence resolved.
This demonstrates that in this POTS subtype, hypocapnia is a primary driver of the orthostatic physiology, not a secondary artifact of sympathetic activation or some other mechanism. The CO₂ drop is doing the physiological work. Restoring it undoes the cascade. No other standard POTS intervention addresses this mechanism.
What Standard Evaluation Misses — and Why It Matters
Standard orthostatic evaluation measures heart rate and blood pressure. It does not measure end-tidal CO₂, respiratory rate, tidal volume, or cerebral blood flow. A patient with the postural hyperventilation subtype will stand on the tilt table, their CO₂ will quietly drop, their cerebral blood flow will fall, their heart rate will climb, and they will receive a standard POTS diagnosis — because by heart rate criteria, they meet the threshold. The evaluation has captured the final step of the chain and nothing preceding it.
The treatment implications of this gap are significant. Beta-blockers blunt the tachycardia but do not address the hypocapnia driving it. Ivabradine reduces heart rate but does not address cerebral hypoperfusion from CO₂-driven vasoconstriction. Volume loading does not prevent the CO₂ drop that is the proximate cause of the cerebrovascular insufficiency. All of these interventions are managing a symptom of the postural hyperventilation rather than the postural hyperventilation itself.
Patients with this subtype may respond partially to standard POTS treatments because tachycardia control provides some hemodynamic benefit regardless of cause. But partial response is not full recalibration. If the mechanism is ventilatory dysregulation triggering CO₂-mediated cerebrovascular constriction, the treatment target is the ventilatory dysregulation — and that requires measuring it first.
Identifying the Postural Hyperventilation Subtype
End-tidal CO₂ monitoring is not expensive or technically complex. It is available in most facilities that perform tilt testing or cardiopulmonary exercise testing. It is simply not routinely included in autonomic evaluations. Adding capnography to tilt table testing would identify which patients are experiencing CO₂ drops during orthostatic stress, allowing clinicians to distinguish the postural hyperventilation subtype from volume-mediated POTS, neuropathic POTS, or hyperadrenergic POTS.
Stewart also reported in the same study that systemic vascular resistance was elevated in the hyperventilating subtype — an unexpected finding given that peripheral pooling and low vascular tone are the more commonly cited POTS mechanisms. This means the postural hyperventilation subtype may present with a hemodynamic profile that differs from the pooling phenotype: high vascular resistance, low cardiac output, low CO₂, normal or near-normal blood pressure. It may even be misread as a different condition entirely without CO₂ data to anchor the interpretation.
What the Reader Needs to Know
If you have POTS and your tachycardia is only partially controlled by standard treatment — or if your most prominent symptoms are cognitive (brain fog, difficulty thinking upright, visual disturbance) rather than presyncope — postural hyperventilation is a mechanism worth investigating. The evaluation requires capnography. It is not standard. You may need to specifically request it, or find a center that includes it in orthostatic evaluation protocols.
The distinction matters because the treatment is different. Managing a breathing-pattern-driven POTS requires addressing the breathing pattern. Knowing that CO₂ restoration normalizes your upright hemodynamics is not an abstract finding. It identifies a mechanism that is, in principle, modifiable — and it identifies the current treatment protocol as one that was calibrated to a different mechanism than the one you actually have.